Molecular Dx firm GeneNews eyes $7.8M from share offering

12/18/2012 | GenomeWeb Daily News (free registration)

GeneNews, a molecular diagnostics firm based in Toronto, hopes to obtain $7.8 million in a private offering of its company stock. The company is in talks to expand the reach of its ColonSentry blood-based assay for colon cancer stratification, which is currently available in New York and New Jersey, across the rest of the U.S., President and CEO Gailina Liew said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC